Found 7 matching trials
This Trial Evaluates Safety, Pharmacokinetic Profile and Anti-viral Response of BI 207127 and BI 201335 for Patients With Chronic Hepatitis C PHASE2 The objective of this trial is to investigate tolerability, safety, pharmac...
Show More Location
1241.25.002 Boehringer Ingelheim Investigational Site
Learn More & Join Trial
Effect of Food and Increased Gastric pH Value on Bioavailability of a Single Dose of BI 207127 in Healthy Caucasian and Japanese Subjects PHASE1 The purpose of this trial is to investigate the effect of food with differe...
Show More Location
1241.44.49001 Boehringer Ingelheim Investigational Site
Learn More & Join Trial
Relative Bioavailability of BI 207127 Trial Formulation II Prototypes Versus BI 207127 Trial Formulation I in Healthy Volunteers PHASE1 Study to investigate the relative bioavailability of 5 new 400 mg tablet fo...
Show More Location
Multiple Locations
Learn More & Join Trial
Safety, Antiviral Effect and PK of BI 207127 + BI 201335 +/- RBV for 4 up to 40 Weeks in Patients With Chronic HCV Genotype 1 Infection PHASE2 The substances BI 201335 and BI 207127 are being developed for the treatmen...
Show More Location
1241.21.0003 Boehringer Ingelheim Investigational Site
Learn More & Join Trial
Multiple Doses of BI 207127 NA, BI 201335 NA Followed by the Combination of BI 207127 NA and BI 201335 NA in Healthy Male Volunteers PHASE1 Study to investigate the pharmacokinetic drug-drug interaction potential of...
Show More Location
Multiple Locations
Learn More & Join Trial
Safety, Tolerability and Pharmacokinetics of Different Multiple Doses of BI 207127 BID and Multiple Doses of BI 207127 Combined With Faldaprevir in Healthy Male and Female Subjects PHASE1 The objective of the current trial is to evaluate safety, tolerability and ...
Show More Location
1241.35.1 Boehringer Ingelheim Investigational Site
Learn More & Join Trial
Study of PPI-668, BI 207127 and Faldaprevir, With and Without Ribavirin, in the Treatment of Chronic Hepatitis C PHASE2 This study is designed to provide a preliminary assessment of the safety an...
Show More Location
Quest Clinical Research
Learn More & Join Trial